G
Gail Mallett
Researcher at Northwestern University
Publications - 19
Citations - 1090
Gail Mallett is an academic researcher from Northwestern University. The author has contributed to research in topics: Medicine & Pregnancy. The author has an hindex of 7, co-authored 12 publications receiving 632 citations.
Papers
More filters
Journal ArticleDOI
Labor Induction versus Expectant Management in Low-Risk Nulliparous Women
William A. Grobman,Madeline Murguia Rice,Uma M. Reddy,Alan T.N. Tita,Robert M. Silver,Gail Mallett,Kim Hill,Elizabeth Thom,Yasser Y. El-Sayed,Annette Perez-Delboy,Dwight J. Rouse,George R. Saade,Kim A. Boggess,Suneet P. Chauhan,Jay D. Iams,Edward K. Chien,Brian M. Casey,Ronald S. Gibbs,Sindhu K. Srinivas,Geeta K. Swamy,Hyagriv N. Simhan,George A. Macones +21 more
TL;DR: Induction of labor at 39 weeks in low‐risk nulliparous women did not result in a significantly lower frequency of a composite adverse perinatal outcome, but it did result in less frequency of cesarean delivery.
Journal ArticleDOI
Labor Induction Versus Expectant Management in Low-Risk Nulliparous Women
William A. Grobman,Madeline Murguia Rice,Uma M. Reddy,Alan T.N. Tita,Robert M. Silver,Gail Mallett,Kim Hill,Elizabeth Thom,Yasser Y. El-Sayed,Annette Perez-Delboy,Dwight J. Rouse,George R. Saade,Kim A. Boggess,Suneet P. Chauhan,Jay D. Iams,Edward K. Chien,Brian M. Casey,Ronald S. Gibbs,Sindhu K. Srinivas,Geeta K. Swamy,Hyagriv N. Simhan,George A. Macones +21 more
TL;DR: Le declenchement du travail a 39 semaines chez les femmes nullipares a faible risque d'evolution perinatale composite indesirable, mais entrainait une frequence significativement plus faible d'accouchements par cesarienne.
Journal ArticleDOI
Follow-up of children exposed in utero to 17 α-hydroxyprogesterone caproate compared with placebo
Allison Northen,Gwendolyn S. Norman,Kristine Anderson,Lisa Moseley,Michelle DiVito,Margaret Cotroneo,Melissa Swain,Sabine Bousleiman,Francee Johnson,Karen F. Dorman,Cynthia Milluzzi,Jo Ann Tillinghast,Marcia Kerr,Gail Mallett,Elizabeth Thom,Susan Pagliaro,Garland D. Anderson +16 more
TL;DR: 17 &agr;-hydroxyprogesterone caproate seems to be safe for the fetus when administered in the second and third trimesters when administered to surviving children of mothers who participated in a multicenter placebo-controlled trial.
Journal ArticleDOI
A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection
Brenna L. Hughes,Rebecca G. Clifton,Dwight J. Rouse,George R. Saade,Mara J. Dinsmoor,Uma M. Reddy,Robert F. Pass,Donna Allard,Gail Mallett,Lida M. Fette,Cynthia Gyamfi-Bannerman,Michael W. Varner,William Goodnight,Alan T.N. Tita,Maged M. Costantine,Geeta K. Swamy,Ronald S. Gibbs,Edward K. Chien,Suneet P. Chauhan,Yasser Y. El-Sayed,Brian M. Casey,Samuel Parry,Hyagriv N. Simhan,Peter G. Napolitano,George A. Macones +24 more
TL;DR: In this article, primary cytomegalovirus (CMV) infection during pregnancy carries a risk of congenital infection and possible severe sequelae and there is no established intervention for preventing it.
Journal ArticleDOI
Antenatal Magnesium and Cerebral Palsy in Preterm Infants
Deborah Hirtz,Steven J. Weiner,Dorothy I. Bulas,Michael A. DiPietro,Joanna J. Seibert,Dwight J. Rouse,Mercer Bm,Michael W. Varner,Uma M. Reddy,Jay D. Iams,Ronald J. Wapner,Yoram Sorokin,John M. Thorp,Susan M. Ramin,Fergal D. Malone,Marshall W. Carpenter,Mary Jo O'Sullivan,Alan M. Peaceman,Gary D.V. Hankins,Donald J. Dudley,Steve N. Caritis,John C. Hauth,Allison Todd,Tawanda Hill,Stacy Harris,Kathleen G. Nelson,Fred J. Biasini,Kristine Anderson,Marla K. Jensen,Lori A. Williams,Lisa H. Fullmer,Anna M. Guzman,Marc Collin,George VanBuren,Cynthia Milluzzi,Monica Fundzak,Cathy Santori,Francee Johnson,Mark B. Landon,Cheryl Latimer,Valerie Curry,Sandra Meadows,Anthony Sciscione,Michelle DiVito,Mary Talucci,Shobhana A. Desai,David A. Paul,Baha M. Sibai,Risa Ramsey,William C. Mabie,Lu Kao,Melanie Cassie,Gwendolyn S. Norman,Debra Driscoll,Barbara Steffy,Mitchell P. Dombrowski,Paul J. Meis,Melissa Swain,Kurt Klinepeter,T. Michael O'Shea,Linda Steele,Kenneth J. Moise,Seth Brody,Janice Bernhardt,Karen F. Dorman,Larry C. Gilstrap,Mary Clare Day,Erin Flinn-Gildersleeve,Felecia Ortiz,Marcia Kerr,Victoria L. Pemberton,Lisa Paley,Charles Paley,Sabine Bousleiman,Vilmarie Carmona,Jo Ann Tillinghast,Donna Allard,Betty R. Vohr,Lucy Noel,Kathleen McCarten,Menachem Miodovnik,Nancy C. Elder,Wendy Girdler,Teresa L. Gratton,Atef H. Moawad,Marshall D. Lindheimer,Phyllis L. Jones,Faith Doyle,Carmen Alfonso,May Scott,Ramona Washington,Gail Mallett,Mercedes Ramos-Brinson,Paula Simon,Tony S. Wen,Linda A. Goodrum,George R. Saade,Gayle Olson,Hassan M. Harirah,Elizabeth Martin,Elly M J Xenakis,Deborah L. Conway,Michael D. Berkus,Theresa M. Kamon,Margaret Cotroneo,Cheryl A. Milford,M. Lynne Sherman,Jody S. Dax,Lisa Fay-Randall,Carla F. Melton,Ester Flores,Elizabeth Thom,Barbara Jones-Binns,Maureen Cooney,Molly L. Fischer,Sarah McLaughlin,Kimberly Brunette,Elizabeth Fricks,Catherine Y. Spong,S. Tolivaisa,Donald McNellis,Charlotte Catz,Kimberly Howell,Karin B. Nelson,James M. Roberts +124 more
TL;DR: MgSO4 given prior to preterm delivery was associated with decreased risk of developing echodensities and echolucencies at <32 weeks gestation, but this effect can only partially explain the effect of M gSO4 on CP at 2 years of age.